Equity Overview
Price & Market Data
Price: $6.31
Daily Change: +$0.141 / 2.24%
Range: $6.00 - $6.40
Market Cap: $236,221,424
Volume: 154,506
Performance Metrics
1 Week: -0.39%
1 Month: -3.33%
3 Months: 0.95%
6 Months: 21.52%
1 Year: -1.09%
YTD: -14.13%
Company Details
Employees: 524
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.